---All---
  • ---All---
  • Accession
  • Catalog #

NADSYN1 Antibody (monoclonal) (M01)Purified Mouse Monoclonal Antibody (Mab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AT2969a 100 ug 400 ul 7-10 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

NADSYN1 Antibody (monoclonal) (M01) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ6IA69
Other AccessionNP_060631
ReactivityHuman
IsotypeIgG1 Kappa
Clone Names4G9
Calculated MW79285 Da

NADSYN1 Antibody (monoclonal) (M01) - Additional info

Gene ID 55191
Other Names
FLJ10631NAD synthetase 1
Target/Specificity
NADSYN1 (-, 609 a.a. ~ 707 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Dilution
WB~~1:500~1000
Format
Clear, colorless solution in phosphate buffered saline, pH 7.2 .
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
NADSYN1 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.

NADSYN1 Antibody (monoclonal) (M01) - Application data

  • NADSYN1 monoclonal antibody (M01), clone 4G9 Western Blot analysis of NADSYN1 expression in Hela NE ( Cat # L013V3 ).

NADSYN1 Antibody (monoclonal) (M01) - Related products

RI13483: NADSYN1 predesign siRNA

AT2969a: NADSYN1 Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).

REFERENCES

Variation at the NFATC2 Locus Increases the Risk of Thiazolinedinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study. Bailey SD, et al. Diabetes Care, 2010 Jul 13. PMID 20628086.Genome-wide association study of circulating vitamin D levels. Ahn J, et al. Hum Mol Genet, 2010 Jul 1. PMID 20418485.Association of genetic variants with hemorrhagic stroke in Japanese individuals. Yoshida T, et al. Int J Mol Med, 2010 Apr. PMID 20198315.Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Talmud PJ, et al. Am J Hum Genet, 2009 Nov. PMID 19913121.Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. Oguri M, et al. Am J Hypertens, 2010 Jan. PMID 19851296.